Showing results (651-660 of 5,929) with videos related to
Sort By:
Pageof 593
The Prostate|November 1, 2008
Engineered measles virus as a novel oncolytic therapy against prostate cancerPavlos Msaouel, Ianko D Iankov, Cory Allen, et al.The Prostate|November 1, 2008
Genome-wide expression analysis of recently processed formalin-fixed paraffin embedded human prostate tissuesThomas A Dunn, Helen Fedor, William B Isaacs, et al.The Prostate|November 1, 2008
Temporal changes in gene expression induced by sulforaphane in human prostate cancer cellsSuvarna Bhamre, Debashis Sahoo, Robert Tibshirani, et al.The Prostate|September 21, 2007
Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotypeFernando U Garcia, Marian M Haber, Xiaoli ChenThe Prostate|February 8, 2007
Secretagogin is a new neuroendocrine marker in the human prostateKatja Adolf, Ludwig Wagner, Anders Bergh, et al.The Prostate|December 5, 2006
Prostate cells express two isoforms of fibroblast growth factor receptor 1 with different affinities for fibroblast growth factor-2Monireh Roghani, David MoscatelliThe Prostate|March 31, 2007
Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblastsHiroyuki Yonou, Yutaka Horiguchi, Yoshio Ohno, et al.The Prostate|March 31, 2007
A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectorsRobert Kraaij, Laura van der Weel, Corrina M A de Ridder, et al.The Prostate|October 23, 2008
PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cellsTisheeka R Graham, Valerie A Odero-Marah, Leland W Chung, et al.The Prostate|October 23, 2008
Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitorFrancis Thomas, Suril Patel, Jeff M P Holly, et al.Pageof 593